David Wallon
@davidwallon_
Followers
32
Following
18
Statuses
19
RT @GJRNicolas: Interested in working on human genome data from @PacBio's technology? Interested in the genetics of Alzheimer's disease? S…
0
11
0
Le #CNRMAJ n'hésite pas en effet à se déplacer pour expliquer le plus simplement possible comment se diagnostique la maladie, quelles sont les lésions et quelles avancées thérapeutiques sont attendues.@franceinfo
0
1
3
RT @GJRNicolas: La journée mondiale contre la maladie d’Alzheimer avait lieu hier. @f3normandie s’est intéressé aux malades jeunes et aux a…
0
3
0
RT @MathiasJucker: We were asked to summarize our thoughts on the recent Aβ-immunotherapy trials and what the next steps need to be - I am…
0
12
0
@GarnierCrussard @VincentPlanche Merci @GarnierCrussard. Tout ceci ne pouvait pas être tranché mais la approche ont été très complémentaire ! Je repiquerai une image montrée dans ce congrès qui illustre un peu le propos...
0
0
2
RT @clouapre: @SFNeurologie @EANeurology @ANAINFrance @LFCE_Epilepsie @SOFMA_fr @FondationARSEP @la_SFNV @Inst_Myologie Félicitations Marie…
0
12
0
RT @Universite_Caen: #Recherche Objectif du projet CIRAANO, porté par l’équipe @Neuropresage de @ChetelatLab : mieux comprendre le cerveau…
0
9
0
@GJRNicolas Thanks @GJRNicolas you were faster than me! But indeed, an extensive description of that rare cause of early onset AD with still an interesting phenotype heterogeneity to understand... (work in progress... ) #Alzheimer #Genetics
0
0
0
RT @GJRNicolas: Wondering about the imaging and clinical phenotype of APP duplication carriers? Here is the description of the French serie…
0
5
0
RT @nvillain_alz: 1/5 I am delighted to share (Open Access) the 1st part of our meta-analysis/review on high-clearance anti-amyloid immunot…
0
10
0
RT @cathmummery: Lilly’s Alzheimer’s drug donanemab succeeds in PhIII trial – 35% slowing of decline in those with intermediate tau levels…
0
50
0
RT @GJRNicolas: How can short read, long read whole genome sequencing and RNAseq help diagnose patients with rare diseases? Our experience…
0
3
0
RT @GJRNicolas: Should SORL1 loss-of-function rare variants be used in genetic counseling of #Alzheimer disease as APP, PSEN1 or PSEN2? Som…
0
10
0
RT @GJRNicolas: And now Olivier Quenez from Rouen presenting the results of rare CNV association with Alzheimer disease in the ADES consort…
0
4
0
RT @guroledip: Congratulations @GJRNicolas @Kevin_Cassinari @GnBresearch @davidwallon_ et al. - "Increased copy number of APP is sufficient…
0
3
0
RT @GJRNicolas: Glad that the first APP triplication is reported by the lab where APP duplications where first reported back in 2006! Thank…
0
1
0
RT @Brain1878: Grangeon et al. show that biallelic MYORG mutations cause primary brain calcification with cerebellar atrophy and a prominen…
0
8
0